InflaRx Presents New Analysis of PANAMO Phase III Trial in S

JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...

Related Keywords

San Diego , California , United States , Germany , Munich , Bayern , American , Inflarx Gmb , Regina Lutz , Camilla Chong , Laurie Doyle , Jan Medina , Katja Arnold , Globenewswire Inc , Inflarx Pharmaceuticals Inc , Inflarx Commitment Program , Drug Administration , American Thoracic Society , International Conference , European Medicines Agency , Mc Services , Thoracic Society , Baricitinib Dramatically Improves Mortality , Critically Ill , Acute Respiratory Failure , Chief Medical Officer , Fact Sheet , Healthcare Providers , Safety Information , Marketing Authorization Application , Medicines Agency ,